Ben Forbes

7.7k total citations · 1 hit paper
158 papers, 5.7k citations indexed

About

Ben Forbes is a scholar working on Pulmonary and Respiratory Medicine, Pharmaceutical Science and Molecular Biology. According to data from OpenAlex, Ben Forbes has authored 158 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Pulmonary and Respiratory Medicine, 51 papers in Pharmaceutical Science and 34 papers in Molecular Biology. Recurrent topics in Ben Forbes's work include Inhalation and Respiratory Drug Delivery (75 papers), Drug Solubulity and Delivery Systems (30 papers) and Advanced Drug Delivery Systems (27 papers). Ben Forbes is often cited by papers focused on Inhalation and Respiratory Drug Delivery (75 papers), Drug Solubulity and Delivery Systems (30 papers) and Advanced Drug Delivery Systems (27 papers). Ben Forbes collaborates with scholars based in United Kingdom, Sweden and Germany. Ben Forbes's co-authors include Gary P. Martin, Marc B. Brown, Carsten Ehrhardt, Stuart A. Jones, C. Grainger, Lea Ann Dailey, David Taylor, David Lockley, James A. Rickard and Steve Pilling and has published in prestigious journals such as PLoS ONE, Advanced Drug Delivery Reviews and Langmuir.

In The Last Decade

Ben Forbes

156 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

2016 1.0k citations Ben Forbes et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ben Forbes United Kingdom	39	1.8k	1.5k	1.1k	951	854	158	5.7k
Thomas P. Johnston United States	52	428 0.2×	1.4k 0.9×	3.1k 2.9×	213 0.2×	766 0.9×	247	9.8k
Jörg Huwyler Switzerland	56	447 0.3×	1.4k 0.9×	4.7k 4.4×	562 0.6×	791 0.9×	277	12.3k
Yunes Panahi Iran	52	455 0.3×	308 0.2×	2.9k 2.7×	290 0.3×	360 0.4×	263	10.3k
Andreas Zimmer Austria	44	490 0.3×	1.7k 1.1×	3.3k 3.1×	70 0.1×	400 0.5×	206	8.1k
Anroop B. Nair Saudi Arabia	46	587 0.3×	3.0k 2.0×	2.9k 2.7×	61 0.1×	830 1.0×	266	11.8k
Shery Jacob United Arab Emirates	34	450 0.3×	1.7k 1.1×	2.0k 1.9×	54 0.1×	283 0.3×	90	7.6k
Yuan Shi China	35	916 0.5×	203 0.1×	1.0k 1.0×	254 0.3×	373 0.4×	247	5.0k
Yoshiaki Kawashimà Japan	56	1.3k 0.7×	6.3k 4.2×	2.7k 2.5×	135 0.1×	924 1.1×	326	11.6k
Paul Benfield New Zealand	41	278 0.2×	247 0.2×	1.2k 1.2×	198 0.2×	515 0.6×	84	6.6k
Ge Li China	46	495 0.3×	399 0.3×	2.8k 2.7×	48 0.1×	478 0.6×	317	7.9k

Countries citing papers authored by Ben Forbes

Since Specialization

Citations

This map shows the geographic impact of Ben Forbes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Forbes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Forbes more than expected).

Fields of papers citing papers by Ben Forbes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben Forbes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Forbes. The network helps show where Ben Forbes may publish in the future.

Co-authorship network of co-authors of Ben Forbes

This figure shows the co-authorship network connecting the top 25 collaborators of Ben Forbes. A scholar is included among the top collaborators of Ben Forbes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ben Forbes. Ben Forbes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shah, Ajit J., et al.. (2025). Design, Synthesis, and Biological Evaluation of Efflux-Resistant Imatinib Derivatives. Journal of Medicinal Chemistry. 68(21). 22619–22632.

Zain, Nur Masirah M., Blair Merrick, Lindsey Edwards, et al.. (2025). Bacterial diversity, viability and stability in lyophilised faecal microbiota capsules support ongoing clinical use. International Journal of Pharmaceutics. 678. 125703–125703. 1 indexed citations

Wang, Julie, Yuan Lü, Khondaker Miraz Rahman, et al.. (2025). Brain distribution study of [14C]-Riluzole following intranasal administration in mice. International Journal of Pharmaceutics. 670. 125195–125195. 1 indexed citations

Li, Haoying, Sally Yunsun Kim, Bahijja Tolulope Raimi‐Abraham, et al.. (2025). Targeted nasal delivery of LNP-mRNAs aerosolised by Rayleigh breakup technology. International Journal of Pharmaceutics. 672. 125335–125335. 4 indexed citations

Forbes, Ben, Lynne Goodacre, Alison B. Lansley, et al.. (2025). Advances in Nasal Biopharmaceutics to Support Product Development and Therapeutic Needs. Pharmaceutics. 17(10). 1321–1321. 1 indexed citations

Pinto, Joana T., Maria Malmlöf, Claudia Meindl, et al.. (2024). Integration of mucus and its impact within in vitro setups for inhaled drugs and formulations: Identifying the limits of simple vs. complex methodologies when studying drug dissolution and permeability. International Journal of Pharmaceutics. 661. 124455–124455. 2 indexed citations

Chan, K. L. Andrew, et al.. (2024). Manufacture and Initial Characterisation of RAPIDTM Biodynamic Haematogel, an Autologous Platelet and Leukocyte-Rich Plasma Gel for Diabetic Foot Ulcers. Gels. 10(9). 572–572. 1 indexed citations

Liu, Ting, et al.. (2024). Pullulan-Based Spray-Dried Mucoadhesive Microparticles for Sustained Oromucosal Drug Delivery. Pharmaceutics. 16(4). 460–460. 7 indexed citations

Lee, Dani Do Hyang, Daniela Cardinale, Priya Radhakrishnan, et al.. (2020). Fluticasone Particles Bind to Motile Respiratory Cilia: A Mechanism for Enhanced Lung and Systemic Exposure?. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 34(3). 181–188. 2 indexed citations

10.

Ball, D.I., Jan Klapwijk, Rory T. Steven, et al.. (2019). Comparison of Oral, Intranasal and Aerosol Administration of Amiodarone in Rats as a Model of Pulmonary Phospholipidosis. Pharmaceutics. 11(7). 345–345. 12 indexed citations

11.

Royall, Paul G., et al.. (2018). Glycerol Solvates DPPC Headgroups and Localizes in the Interfacial Regions of Model Pulmonary Interfaces Altering Bilayer Structure. Langmuir. 34(23). 6941–6954. 24 indexed citations

12.

Clifford, Vanessa, Marc Tebruegge, Christel Zufferey, et al.. (2018). Cytokine biomarkers for the diagnosis of tuberculosis infection and disease in adults in a low prevalence setting. Tuberculosis. 114. 91–102. 37 indexed citations

13.

Kumar, Abhinav, Paul Pfeffer, Marco P. Monopoli, et al.. (2017). Differences in the coronal proteome acquired by particles depositing in the lungs of asthmatic versus healthy humans. Nanomedicine Nanotechnology Biology and Medicine. 13(8). 2517–2521. 12 indexed citations

14.

Forbes, Ben, et al.. (2011). Bile salt composition is secondary to bile salt concentration in determining hydrocortisone and progesterone solubility in intestinal mimetic fluids. International Journal of Pharmaceutics. 422(1-2). 295–301. 16 indexed citations

15.

Bosquillon, Cynthia, et al.. (2009). In-vitro respiratory drug absorption models possess nominal functional P-glycoprotein activity. Journal of Pharmacy and Pharmacology. 61(3). 293–301. 35 indexed citations

16.

Forbes, Ben, et al.. (2008). Phenylalanine 4-monooxygenase and the S-Oxidation of S-Carboxymethyl-L-cysteine by Human Cytosolic Fractions. Drug metabolism and drug interactions. 23(3-4). 261–282. 13 indexed citations

17.

Patel, Jay, Gary P. Martin, Luc Delattre, et al.. (2006). Use of the MTT assay to evaluate the biocompatibility of beta-cyclodextrin derivatives with respiratory epithelial cells. Open Repository and Bibliography (University of Liège). 3 indexed citations

18.

Liao, Yonghong, Stuart A. Jones, Ben Forbes, Gary P. Martin, & Marc B. Brown. (2005). Hyaluronan: Pharmaceutical Characterization and Drug Delivery. Drug Delivery. 12(6). 327–342. 254 indexed citations

19.

Forbes, Ben. (2003). Pulmonary Epithelial Cell Culture. Humana Press eBooks. 188. 65–75. 2 indexed citations

20.

Forbes, Ben, Sian Lim, Gary P. Martin, & Marc B. Brown. (2002). An in vitro technique for evaluating inhaled nasal delivery systems. Research Portal (King's College London). 12(1). 75–79. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact